Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
31 results
D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial
D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial
D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial
D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study
D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study
D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis
D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial
D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to
D2.499 - Immunoregulatory Effects of Dupilumab Added to Omalizumab-Facilitated Multi-Allergen Oral Immunotherapy in the COMBINE clinical trial
D2.503 - LP-003 Injection for the treatment of H1 Antihistamine-Inadequately Controlled Chronic Spontaneous Urticaria (CSU): A Multicenter, Randomized, Double-Blind, Controlled Phase Ⅱ Study
D2.504 - Novel food supplement containing a combination of bioactive compounds in pediatric cow’s milk protein allergy: results from a randomized, placebo-controlled trial
D3.385 - A Synthetic Serum Comprising Human IgE Monoclonal Antibodies to Peanut Allergens
D3.386 - Prevalence and immune mechanisms of rheumatoid arthritis in Kyrgyz highland residents
D3.387 - Assessment of safety of cryopreserved mesenchymal stem cells in the treatment of atopic dermatitis
D3.388 - Association of HLA and cytokine production as risk factors for prostate cancer
D3.389 - The Role Of Metabolic Endotoxemia In The Development Of Systemic Inflammation In Patients With Type 1 And Type 2 Diabetes Mellitus
D3.390 - Lipopolysaccharide-Binding Protein And sCd14 In Patients With Type 1 Diabetes Mellitus And Diabetic Nephropathy
D3.391 - The Effect of Bicarbonate Mineral Water on Endotoxemia Markers in Patients with Type 1 Diabetes Mellitus
D3.392 - Associations Between Markers Of Endotoxin-Binding Systems And Vasoactive Agents In Patients With Rheumatoid Arthritis
D3.393 - Immunological Profiling of the Kras-Driven Microenvironment in a Murine Model of Endometriosis
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download